Sleep and immunotherapy for lung cancer
Part of Brain & nervous system, Cancer, Lungs & breathing, Mental health clinical trials.
This study looks at how your sleep might affect how well immunotherapy works for lung cancer. By joining, you'll help doctors learn if improving sleep could make treatment more effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-small-cell lung cancer, stage II to IV (meaning the cancer is locally advanced or has spread).
- You are 18 years old or older.
- You are planning to start immunotherapy (treatment like nivolumab or pembrolizumab).
- You are able to understand the study and give your permission to participate.
- You do not have a serious mental illness (such as major depression or anxiety).
- You have not recently had chemotherapy or radiation therapy, and you do not have other serious health conditions like heart, liver, or kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects blood and sputum (phlegm) samples from people with lung cancer before and during immunotherapy. The goal is to see if certain immune markers in these samples can predict how well the treatment works.
This study looks at how sleep problems affect your body's immune response to lung cancer. It aims to find links between sleep and the tumor environment, which could help improve treatment.
This study looks at how sleep disturbances affect how well lung cancer treatments work. It may help doctors understand if improving sleep can lead to better treatment results.
This trial tests whether the time of day you receive immunotherapy (in the morning vs. later) affects how well it works. It is for people with advanced lung cancer or other solid tumors who are just starting or continuing PD-1/PD-L1 inhibitor treatment.
This study looks at how your immune system works in non-small cell lung cancer and whether it predicts how well you'll respond to a type of immunotherapy called anti-PD-1/PD-L1 drugs. Researchers will study your tumor tissue to understand why some patients benefit more than others.
This study looks at whether sleep disorders influence how lung tumors develop after surgery. It may help doctors understand the link between sleep and recovery, which could lead to better care.
Hear when a new Lung Cancer (NSCLC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.